Limiting the Spread of Multidrug-Resistant Bacteria in Low-to-Middle-Income Countries: One Size Does Not Fit All.

antimicrobial resistance and low-to-middle income countries infection control multidrug-resistant organisms

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
14 Jan 2023
Historique:
received: 09 11 2022
revised: 05 01 2023
accepted: 06 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 22 1 2023
Statut: epublish

Résumé

The spread of multidrug-resistant organisms (MDRO) is associated with additional costs as well as higher morbidity and mortality rates. Risk factors related to the spread of MDRO can be classified into four categories: bacterial, host-related, organizational, and epidemiological. Faced with the severity of the MDRO predicament and its individual and collective consequences, many scientific societies have developed recommendations to help healthcare teams control the spread of MDROs. These international recommendations include a series of control measures based on surveillance cultures and the application of barrier measures, ranging from patients' being isolated in single rooms, to the reinforcement of hand hygiene and implementation of additional contact precautions, to the cohorting of colonized patients in a dedicated unit with or without a dedicated staff. In addition, most policies include the application of an antimicrobial stewardship program. Applying international policies to control the spread of MDROs presents several challenges, particularly in low-to-middle-income countries (LMICs). Through a review of the literature, this work evaluates the real risks of dissemination linked to MDROs and proposes an alternative policy that caters to the means of LMICs. Indeed, sufficient evidence exists to support the theory that high compliance with hand hygiene and antimicrobial stewardship reduces the risk of MDRO transmission. LMICs would therefore be better off adopting such low-cost policies without necessarily having to implement costly isolation protocols or impose additional contact precautions.

Identifiants

pubmed: 36678492
pii: pathogens12010144
doi: 10.3390/pathogens12010144
pmc: PMC9866331
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Hosp Infect. 2021 May;111:155-161
pubmed: 33581244
Lancet Infect Dis. 2019 Oct;19(10):1069-1079
pubmed: 31451419
J Hosp Infect. 2015 Apr;89(4):241-7
pubmed: 25737092
J Infect. 2021 Aug;83(2):156-166
pubmed: 34000343
BMJ Open. 2016 Jan 29;6(1):e009029
pubmed: 26826145
Front Public Health. 2018 Aug 02;6:212
pubmed: 30116726
Ann N Y Acad Sci. 2014 Sep;1323:22-42
pubmed: 25195939
J Hosp Infect. 2021 Dec;118:48-58
pubmed: 34492304
Antimicrob Resist Infect Control. 2021 Jan 29;10(1):22
pubmed: 33514432
JAMA. 2013 Oct 16;310(15):1571-80
pubmed: 24097234
Clin Microbiol Infect. 2015 May;21(5):470.e1-7
pubmed: 25684452
Am J Infect Control. 2012 Nov;40(9):845-8
pubmed: 22325483
Clin Microbiol Infect. 2011 Aug;17(8):1201-8
pubmed: 21054665
Lancet Infect Dis. 2014 Jan;14(1):31-39
pubmed: 24161233
Clin Microbiol Rev. 2013 Jul;26(3):361-80
pubmed: 23824364
Am J Infect Control. 2013 Nov;41(11):976-8
pubmed: 23890745
Am J Infect Control. 2009 Mar;37(2):85-93
pubmed: 19249637
Emerg Microbes Infect. 2022 Dec;11(1):443-451
pubmed: 35034585
J Appl Bacteriol. 1996 Apr;80(4):458-64
pubmed: 8849649
J Exp Med. 2019 Jan 7;216(1):10-19
pubmed: 30309968
J Hyg (Lond). 1971 Sep;69(3):405-11
pubmed: 4999450
Clin Infect Dis. 2015 Aug 15;61(4):593-600
pubmed: 25904368
Clin Microbiol Infect. 2017 Mar;23(3):188-196
pubmed: 27746394
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4554-61
pubmed: 20847294
Euro Surveill. 2017 Feb 9;22(6):
pubmed: 28205502
Infect Control Hosp Epidemiol. 2009 Jun;30(6):534-42
pubmed: 19419270
Clin Infect Dis. 2014 Mar;58(5):697-703
pubmed: 24304707
Am J Infect Control. 2010 Jun;38(5):361-7
pubmed: 20189267
Infect Control Hosp Epidemiol. 2011 May;32(5):481-9
pubmed: 21515979
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28717036
J Antimicrob Chemother. 2009 Mar;63(3):609-14
pubmed: 19151036
Public Health. 2015 Jul;129(7):979-88
pubmed: 25818015
J Hosp Infect. 2020 Apr 18;:
pubmed: 32315668
Infect Control Hosp Epidemiol. 2013 Aug;34(8):809-17
pubmed: 23838221
Infect Control Hosp Epidemiol. 2013 Jul;34(7):730-9
pubmed: 23739078
Clin Infect Dis. 2001 Apr 15;32(8):1162-71
pubmed: 11283805
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1315-1322
pubmed: 27609341
PLoS Biol. 2008 Nov 18;6(11):e280
pubmed: 19018661
Clin Microbiol Rev. 2013 Oct;26(4):744-58
pubmed: 24092853
Crit Care Med. 2012 Apr;40(4):1045-51
pubmed: 22202707
Nature. 2014 Jan 23;505(7484):559-63
pubmed: 24336217
BMC Med. 2018 Jun 4;16(1):78
pubmed: 29860943
Clin Infect Dis. 2019 Feb 15;68(5):873-884
pubmed: 30475989
J Hosp Infect. 2017 Jan;95(1):3-45
pubmed: 27890334
J Antimicrob Chemother. 2012 Jul;67(7):1597-606
pubmed: 22499996
Euro Surveill. 2015;20(45):
pubmed: 26675038
Front Microbiol. 2016 May 26;7:788
pubmed: 27303380
Arch Intern Med. 2009 Aug 10;169(15):1372-8
pubmed: 19667299
N Engl J Med. 2011 Apr 14;364(15):1407-18
pubmed: 21488763
Antimicrob Resist Infect Control. 2017 Nov 15;6:113
pubmed: 29163939
Clinics (Sao Paulo). 2013;68(8):1128-33
pubmed: 24037009
Int J Infect Dis. 2021 Oct;111:326-327
pubmed: 34496303
Microbiol Spectr. 2015 Jun;3(3):
pubmed: 26185088
J Antimicrob Chemother. 2013 Apr;68(4):731-42
pubmed: 23208830
BMC Infect Dis. 2007 Jun 21;7:61
pubmed: 17584935
Arch Intern Med. 1998 May 25;158(10):1127-32
pubmed: 9605785
Med Mal Infect. 2014 Feb;44(2):51-6
pubmed: 24360201
Infect Control Hosp Epidemiol. 2000 Nov;21(11):718-23
pubmed: 11089656
Infect Control Hosp Epidemiol. 2013 Nov;34(11):1160-6
pubmed: 24113599
Infection. 2014 Oct;42(5):883-90
pubmed: 25008195
Clin Infect Dis. 2021 Feb 1;72(3):431-437
pubmed: 31970393
J Clin Microbiol. 2015 Aug;53(8):2709-12
pubmed: 25994164
Clin Infect Dis. 2013 Dec;57(11):1593-9
pubmed: 23934166
PLoS One. 2015 Oct 02;10(10):e0139883
pubmed: 26431402
Environ Sci Technol. 2015 Oct 20;49(20):11993-2004
pubmed: 26355462
Infection. 2014 Dec;42(6):1013-22
pubmed: 25143193
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1811-7
pubmed: 22246509
Clin Infect Dis. 2017 May 15;64(suppl_2):S51-S60
pubmed: 28475791
Antimicrob Agents Chemother. 2001 Apr;45(4):1151-61
pubmed: 11257029
Intensive Care Med. 2013 Dec;39(12):2153-60
pubmed: 23995982
Curr Opin Infect Dis. 2013 Aug;26(4):338-44
pubmed: 23743816
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28971864
Infect Control Hosp Epidemiol. 2007 Oct;28(10):1142-7
pubmed: 17828690
Lancet Infect Dis. 2020 May;20(5):575-584
pubmed: 32087113
Clin Microbiol Infect. 2018 Jan;24(1):3-5
pubmed: 28970162
Lancet. 1996 Dec 14;348(9042):1615-9
pubmed: 8961991
Clin Infect Dis. 2012 Dec;55(11):1505-11
pubmed: 22955436
Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3151-61
pubmed: 22814876
Lancet. 2011 Jan 15;377(9761):228-41
pubmed: 21146207
Lancet. 2016 Jan 9;387(10014):168-75
pubmed: 26603918
J Hosp Infect. 2021 Jul;113:1-9
pubmed: 33932556
Arch Intern Med. 2006 Oct 9;166(18):1945-51
pubmed: 17030826
Am J Infect Control. 2009 Mar;37(2):106-10
pubmed: 18945520
Antimicrob Resist Infect Control. 2017 May 15;6:47
pubmed: 28515903
Am J Infect Control. 2013 Jul;41(7):664
pubmed: 23398771
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Clin Infect Dis. 2009 Mar 15;48(6):766-71
pubmed: 19196174
Euro Surveill. 2018 Feb;23(8):
pubmed: 29486831
Intensive Care Med. 2012 Dec;38(12):1930-45
pubmed: 23011531
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6908-13
pubmed: 10359812
Infect Control Hosp Epidemiol. 2017 Jan;38(1):53-60
pubmed: 27817759
Immunol Rev. 2017 Sep;279(1):90-105
pubmed: 28856737
Clin Infect Dis. 2006 Feb 1;42(3):370-6
pubmed: 16392083
Clin Infect Dis. 2011 Apr 1;52(7):848-55
pubmed: 21317398
J Antimicrob Chemother. 2013 Sep;68(9):2144-53
pubmed: 23674762
Crit Care Med. 2010 Aug;38(8 Suppl):S299-305
pubmed: 20647787
Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1615-20
pubmed: 25957988
J Clin Microbiol. 2013 Jan;51(1):177-81
pubmed: 23115260
Clin Infect Dis. 2008 Mar 1;46(5):678-85
pubmed: 18230044
Infect Control Hosp Epidemiol. 2013 Jan;34(1):69-73
pubmed: 23221195
N Engl J Med. 2000 Dec 28;343(26):1925-32
pubmed: 11136263
Int J Antimicrob Agents. 2017 Aug;50(2):127-134
pubmed: 28647532
Science. 2005 Jun 10;308(5728):1635-8
pubmed: 15831718
Infect Control Hosp Epidemiol. 2007 Jan;28(1):42-9
pubmed: 17230386
Infect Control Hosp Epidemiol. 2020 Jan;41(1):1-18
pubmed: 31767041
Antibiotics (Basel). 2019 Aug 10;8(3):
pubmed: 31405146
Ned Tijdschr Geneeskd. 2012;156(38):A5233
pubmed: 22992249

Auteurs

Rindala Saliba (R)

Clinical Microbiology Department, Hotel-Dieu de France University Hospital, Beirut 1100, Lebanon.
Laboratoire des Agents Pathogènes, Saint-Joseph University of Beirut, Beirut 1100, Lebanon.
Faculty of Medicine, Saint-Joseph University of Beirut, Beirut 1100, Lebanon.

Jean-Ralph Zahar (JR)

Infection Prevention and Control Department, Avicenne University Hospital, 93000 Bobigny, France.

Georges Dabar (G)

Faculty of Medicine, Saint-Joseph University of Beirut, Beirut 1100, Lebanon.
Pulmonology and Critical Care Department, Hotel-Dieu de France University Hospital, Beirut 1100, Lebanon.

Moussa Riachy (M)

Faculty of Medicine, Saint-Joseph University of Beirut, Beirut 1100, Lebanon.
Pulmonology and Critical Care Department, Hotel-Dieu de France University Hospital, Beirut 1100, Lebanon.

Dolla Karam-Sarkis (D)

Laboratoire des Agents Pathogènes, Saint-Joseph University of Beirut, Beirut 1100, Lebanon.

Rola Husni (R)

School of Medicine, Lebanese American University, Beirut 1100, Lebanon.
Lebanese American University Medical Center, Rizk Hospital, Beirut 1100, Lebanon.

Classifications MeSH